DocDollars

Biocompatibles, Inc.

MA · United States · Reporting entity ID 100000011081

Total reported 2019–2025
$1.56M
#1,139 of 2,960 reporting companies — 0% of all reported industry payments
$1.45M in general payments across 4,727 records, plus $113K in research funding across 65 records.

How it breaks down

General payments $1,449,828
Research funding $113,465

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Biocompatibles, Inc. reported $1.56M to US doctors and teaching hospitals from 2019 to 2025, ranking #1,139 of 2,960 reporting companies. 7% of that was research funding and 93% general payments such as consulting, speaking, food and travel. 4,727 general payment records and 65 research records were filed.

Common questions about Biocompatibles, Inc.

How much has Biocompatibles, Inc. paid US doctors?

Biocompatibles, Inc. reported $1,563,293 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,449,828 in general payments, $113,465 in research funding.

How does Biocompatibles, Inc. rank among drug and device companies?

It ranks #1,139 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Biocompatibles, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.